AU2595000A - Integrated portable biological detection system - Google Patents
Integrated portable biological detection system Download PDFInfo
- Publication number
- AU2595000A AU2595000A AU25950/00A AU2595000A AU2595000A AU 2595000 A AU2595000 A AU 2595000A AU 25950/00 A AU25950/00 A AU 25950/00A AU 2595000 A AU2595000 A AU 2595000A AU 2595000 A AU2595000 A AU 2595000A
- Authority
- AU
- Australia
- Prior art keywords
- integrated system
- integrated
- sample
- electrodes
- amplification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title description 22
- 210000004027 cell Anatomy 0.000 claims description 207
- 239000000523 sample Substances 0.000 claims description 96
- 238000004458 analytical method Methods 0.000 claims description 61
- 238000006243 chemical reaction Methods 0.000 claims description 58
- 230000003321 amplification Effects 0.000 claims description 53
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 53
- 238000000926 separation method Methods 0.000 claims description 36
- 238000002360 preparation method Methods 0.000 claims description 34
- 238000009396 hybridization Methods 0.000 claims description 28
- 238000009739 binding Methods 0.000 claims description 23
- 230000027455 binding Effects 0.000 claims description 22
- 239000011159 matrix material Substances 0.000 claims description 20
- 238000010438 heat treatment Methods 0.000 claims description 16
- 230000009089 cytolysis Effects 0.000 claims description 15
- 108091005804 Peptidases Proteins 0.000 claims description 14
- 239000004365 Protease Substances 0.000 claims description 14
- 238000005286 illumination Methods 0.000 claims description 14
- 239000003446 ligand Substances 0.000 claims description 13
- 239000000758 substrate Substances 0.000 claims description 13
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 11
- 239000012472 biological sample Substances 0.000 claims description 10
- 230000005855 radiation Effects 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 8
- 108090000790 Enzymes Proteins 0.000 claims description 8
- 230000006037 cell lysis Effects 0.000 claims description 8
- 108010067770 Endopeptidase K Proteins 0.000 claims description 7
- 210000000170 cell membrane Anatomy 0.000 claims description 7
- 210000001236 prokaryotic cell Anatomy 0.000 claims description 7
- 230000003993 interaction Effects 0.000 claims description 6
- 238000006911 enzymatic reaction Methods 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 claims 4
- 238000007900 DNA-DNA hybridization Methods 0.000 claims 3
- 230000009149 molecular binding Effects 0.000 claims 3
- 238000007899 nucleic acid hybridization Methods 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 description 45
- 108020004707 nucleic acids Proteins 0.000 description 43
- 102000039446 nucleic acids Human genes 0.000 description 43
- 238000000034 method Methods 0.000 description 40
- 239000000463 material Substances 0.000 description 27
- 108090000623 proteins and genes Proteins 0.000 description 25
- 102000004169 proteins and genes Human genes 0.000 description 22
- 239000000872 buffer Substances 0.000 description 17
- 238000012545 processing Methods 0.000 description 16
- 238000002493 microarray Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 108020004414 DNA Proteins 0.000 description 12
- 238000011282 treatment Methods 0.000 description 12
- 239000003153 chemical reaction reagent Substances 0.000 description 11
- 238000004720 dielectrophoresis Methods 0.000 description 11
- 241000894006 Bacteria Species 0.000 description 10
- 210000000601 blood cell Anatomy 0.000 description 9
- 238000011033 desalting Methods 0.000 description 9
- 238000003752 polymerase chain reaction Methods 0.000 description 9
- 108700026220 vif Genes Proteins 0.000 description 9
- 230000008569 process Effects 0.000 description 8
- 101150064691 Q gene Proteins 0.000 description 7
- 238000003556 assay Methods 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000003527 eukaryotic cell Anatomy 0.000 description 7
- 230000000717 retained effect Effects 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- 239000012530 fluid Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 230000001413 cellular effect Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 235000019419 proteases Nutrition 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 101710163270 Nuclease Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 239000012491 analyte Substances 0.000 description 4
- 239000012620 biological material Substances 0.000 description 4
- 208000019065 cervical carcinoma Diseases 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 239000012510 hollow fiber Substances 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 238000002032 lab-on-a-chip Methods 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 229920000936 Agarose Polymers 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 241000191938 Micrococcus luteus Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 241001138501 Salmonella enterica Species 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 230000005684 electric field Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 230000009871 nonspecific binding Effects 0.000 description 3
- 108091033319 polynucleotide Proteins 0.000 description 3
- 102000040430 polynucleotide Human genes 0.000 description 3
- 239000002157 polynucleotide Substances 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 241000894007 species Species 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- 108091093088 Amplicon Proteins 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108091005461 Nucleic proteins Proteins 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 238000003491 array Methods 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000000835 electrochemical detection Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 238000012632 fluorescent imaging Methods 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 101150114988 invA gene Proteins 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000002934 lysing effect Effects 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 101150021607 rppH gene Proteins 0.000 description 2
- 101150082821 sacA gene Proteins 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 101150070603 yadA gene Proteins 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 230000007023 DNA restriction-modification system Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- RZCIEJXAILMSQK-JXOAFFINSA-N TTP Chemical compound O=C1NC(=O)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 RZCIEJXAILMSQK-JXOAFFINSA-N 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000005465 channeling Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000005518 electrochemistry Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- CPBQJMYROZQQJC-UHFFFAOYSA-N helium neon Chemical compound [He].[Ne] CPBQJMYROZQQJC-UHFFFAOYSA-N 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002605 large molecules Chemical class 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000010208 microarray analysis Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000004377 microelectronic Methods 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004976 peripheral blood cell Anatomy 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000008057 potassium phosphate buffer Substances 0.000 description 1
- 230000000135 prohibitive effect Effects 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000005464 sample preparation method Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1429—Signal processing
- G01N15/1433—Signal processing using image recognition
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1484—Optical investigation techniques, e.g. flow cytometry microstructural devices
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Signal Processing (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Electrostatic Separation (AREA)
Description
WO 00/37163 PCT/US99/31098 INTEGRATED PORTABLE BIOLOGICAL DETECTION SYSTEM GOVERNMENT SUPPORT The Government has rights in this invention pursuant to Grant No. ATP: 5 70NANB7H3001 awarded by the Advanced Technology Program. FIELD OF THE INVENTION This invention relates to .devices and methods for performing active, multi-step sample preparation and molecular diagnostic analysis of biological materials. More 10 particularly, it relates to integrated, compact, portable devices for self-contained sample to answer systems. Specifically, this invention relates to a device and method for performing multi-step sample preparation #nd assay on either two or even a single microchip. Examples of applications for .this integrated system include food and/or quality monitoring, diagnosis of infectionsidiseases and cancers, bone marrow plastesis (e.g., stem 15 cell separation and analysis), aiidfenetics-based identification of individuals for forensic purposes. RELATED APPLICATIONS This application claims benefit of provisional patent application no. 60/113,730, 20 filed December 23, 1998, entitled "Fluorescent Imaging of Cells and Nucleic Acids in Bioelectronic Chips", and is a continuation-in-part of co-pending Application Serial No. 09/016,596, filed on January 30, 1998, entitled "Channel-Less Separation of Bioparticles on a Bioelectronic Chip by Dielectrophoresis", which is a continuation in part of co pending Application Serial No. 08/709,358, filed on September 6, 1996, entitled 25 "Apparatus and Methods for Active Biological Sample Preparation", and is a continuation-in-part of co-pending Application Serial No. 08/986,065, filed on December 5, 1997, entitled "Self-Addressable Self-Assembling Microelectronic Integrated Systems, Component Devices, Mechanisms, Methods, and Procedures for Molecular Biological Analysis and Diagnostics", which is a continuation-in-part of Application Serial No. 30 08/534,454, filed September 27, 1995, entitled "Apparatus and Methods for Active Programmable Matrix Devices", now issued as U.S. Patent. No. 5,849,486, which is a continuation-in-part of Application Serial No. 08/304,657, filed September 9, 1994, WO 00/37163 PCT/US99/31098 2 entitled "Automated Molecular Biological Diagnostic System", now issued as U.S. Patent No. 5,632,957, which is a continuation-in-part of Application Serial No. 08/271,882, filed July 7, 1994, entitled "Methods for Electronic Stringency Control for Molecular Biological Analysis and Diagnostics", now allowed, the specifications of which are hereby 5 incorporated by reference as fully set forth herein. BACKGROUND OF THE INVENTION The following description provides a summary of information relevant to the present invention. It is not an admission that any of the information provided herein is 10 prior art to the presently claimed invention, nor that any of the publications specifically or implicitly referenced are prior art to the invention. Generally, analysis of biological-derived sample materials cannot occur until the sample is processed through numerous pre-analysis steps. Often, the preparation process is time consuming and laborious. For example, many immuno and molecular-biological 15 diagnostic assays on clinical samples, such as blood or tissue cells, require separation of the molecules of interest from the crude sample by disrupting or lysing the cells to release such molecules including proteins and nucleic acids (i.e., DNA and RNA) of interest, followed by purification of such proteins and/or nucleic acids. Only after performing processing steps can analysis of the molecules of interest begin. Additionally, protocols used for the actual 20 analysis of the samples require numerous more steps before useful data is obtained. For example, charged and uncharged microparticles in solution (such as cellular material or crude extracts of protein or nucleic acids thereof) may be separated by dielectrophoresis. On a microscale, dielectrophoresis can be performed using a glass slide based device having exposed, i.e., naked, interdigitated electrodes plated on the surface of the 25 slide and having a flow chamber with a volume of several hundred microliters. With such a device, cells, proteins, and nucleic acids can be separated based on their respective dielectric properties by using separation buffers having appropriate conductivity and an AC signal with a suitable amplitude and frequency. Such devices, however, have several problems including the nonspecific binding of both separated and unseparated cells to exposed portions of the 30 glass surface and the electrodes. Such devices are also problematic in that the flow chamber volume (several hundred microliters) is so large that thermal convection can disturb and push materials such as cells and large molecules initially attracted to and retained by the electrodes WO 00/37163 PCT/US99/31098 3 off of the electrodes. Additionally, undesired cells and molecules are not easily washed off the surface without disturbing and loosing the desired cells as such cells and molecules can interfere with fluidic flow and, hence, block the flow during wash steps. Conventional methods to disrupt whole cells for the release of proteins and nucleic 5 acids have employed the use of a series of high voltage DC pulses in a macrodevice, as opposed to a microchip-based device. Such conventional electronic lysis techniques have several problems. For example, some commercial macro-devices use lysis conditions that do not release high molecular weight (larger than 20 Kb) nucleic acids because the high molecular weight molecules can not fit through pores created in the cell membranes using 10 such methods. Additionally, released nucleic acids are often lost due to their non-specific binding to the surface of the lysis chamber. Such loss of material, especially when molecules of interest are in low concentration, is further compounded by the fact that the dielectro phoretic cell separation macro-device systems are stand alone systems allowing for loss of sample in the transfer of material from one device to the other as sample preparation is 15 carried forward. Processing of the crude lysate often requires chemical reactions to remove undesired cellular components from the specifically desired ones. These reactions typically include subjecting the lysate to enzymatic reactions such as proteinase K and restriction enzymes or nucleases. Processing can also include enhancing the presence of desired molecules, 20 particularly nucleic acids, by performing amplification reactions such as by strand displacement amplification (SDA) or polymerase chain reaction (PCR) methodologies. These reactions are also carried out in stand-alone processes. Only after these sample prepa ration and processing steps can assaying for data retrieval begin. Because of the numerous steps between sample collection and assay, many a technique is limited in its application by a 25 lack of sensitivity, specificity, or reproducibility. Attempts have been made to use dielectrophoresis to ,separate and identify whole cells. For example, U.S. Patent No. 4,326,934 to Pohl discloses a method and apparatus for cell classification by continuous dielectrophoresis. With such method cells are separated by making use of both the positive and negative dielectrophoretic movement of cell particles. 30 Separated cells are allowed to be characterized and/or classified by viewing the characteristic deflection distance of cells moving through the positive and negative electrodes.
WO 00/37163 PCT/US99/31098 4 In another example, U.S. Patent No. 5,344,535 to Belts et al. discloses a method and apparatus for the characterization of micro-organisms and other particles by dielectro phoresis. In this system, cells are characterized by matching their signature dielectrophoretic collection rates. 5 In yet another example, U.S. Patent No. 5,569,367 to Belts et al. discloses a method and apparatus for separating a mixture of cells using a pair of energized interdigitated electrodes comprised of interweaved grid-like structures arranged to obstruct flow of cells through the appratus and cause differentiation of cell types into fractions by applying a non uniform alternating field. 10 In addition, other attempts have been made to combine certain processing steps or substeps together. For example, various microrobotic systeis have been proposed for preparing arrays of DNA probes on a support material. Beattie et al., disclose in "The 1992 San Diego Conference: Genetic Recognition", November, 1992, use of a microrobotic system to deposit micro-droplets containing specific DNA sequences into individual 15 microfabricated sample wells on a glass substrate. Various other attempts have been made to describe integrated systems formed on a single chip or substrate, wherein multiple steps of an overall sample preparation and diagnostic system would be included. A. Manz et al., in "Miniaturized Total Chemical Analysis System: A Novel Concept For Chemical Sensing", Sensors And Actuators, 20 B 1(1990), pp. 244-248, describe a 'total chemical analysis system' (TAS) that comprises a modular construction of a miniaturized TAS. In that system, sample transport, chemical reactions, chromatographic separations and detection were to be automatically carried out. Yet another proposed integrated system by Stapleton, U.S. Patent No. 5,451,500, a system for automated detection of target nucleic acid sequences is described. In this system 25 multiple biological samples are individually incorporated into matrices containing carriers in a two-dimensional format. Various multiple electrode systems are also disclosed which purport to perform multiple aspects of biological sample preparation or analysis. Pace, U.S. Patent 4,908,112, entitled "Silicon Semiconductor Wafer for Analyzing Micronic Biological Samples" 30 describes an analytical separation device in which a capillary-sized conduit is formed by a channel in a semiconductor device, wherein electrodes are positioned in the channel to activate motion of liquids through the conduit. Additionally, Soane et al., in U.S. Patent WO 00/37163 PCT/US99/31098 5 5,126,022, entitled "Method and Device for Moving Molecules by the Application of a Plurality of Electrical Fields", describes a system by which materials are moved through trenches by application of electric potentials to electrodes in which selected components may be guided to various trenches filled with antigen-antibodies reactive with given charged 5 particles being moved in the medium or moved into contact with complementary components, dyes, fluorescent tags, radiolabels, enzyme-specific tags or other types of chemicals for any number of purposes such as various transformations which are either physical or chemical in nature. Further, Clark, et al. in U.S. Patent 5,194,133, entitled "Sensor Devices", discloses a sensor device for the analysis of a sample fluid which includes 10 a substrate having a surface in which is formed an elongate micro-machined channel con taining a material, such as starch, agarose, alginate, carrageenan or polyacrylamide polymer gel, for causing separation of the sample fluid as the fluid passes along the channel. The biological material may comprise, for example, a binding protein, an antibody, a lectin, an enzyme, a sequence of enzymes, or a lipid. 15 Various devices for eluting DNA from various surfaces are known. For example, Shukla U.S. Patent 5,340,449, entitled "Apparatus for Electroelution" describes a system and method for the elution of macromolecules such as proteins and nucleic acids from solid phase matrix materials such as polyacrylamide, agarose and membranes such as PVDF in an electric field. Materials are eluted from the solid phase into a volume defined in part by 20 molecular weight cut-off membranes. Also, Okano, et al. in U.S. Patent 5,434,049, entitled "Separation of Polynucleotides Using Supports Having a Plurality of Electrode-Containing Cells" discloses a method for detecting a plurality of target polynucleotides in a sample, the method including the step of applying a potential to individual chambers so as to serve as electrodes to elute captured target polynucleotides, the eluted material is then available for 25 collection. Other devices for performing nucleic acid diagnosis have been- designed wherein at least two reaction chambers are necessary for carryout the sample preparation and analysis such as R. Lipshutz, et al., entitled "Integrated Nucleic Acid Diagnostic Device" (U.S. Patent No. 5,856,174) and R. Anderson, et al., entitled "Integrated Nucleic Acid Diagnostic 30 Device", (U.S. Patent No. 5,922,591). Still other achievements have been made toward partial integration of a complete sample handling system such as P. Wilding, et al., "Integrated cell isolation and PCR WO 00/37163 PCTIUS99/31098 6 analysis using silicon microfilter-chambers," Anal. Biochem.257, pp. 95-100, 1998; and P.C.H. Li and D.J. Harrison, "Transport, manipulation, and reaction of biological cells on chip using electrokinetic effects," Anal. Chem., 69, pp. 1564-1568, 1997. Still others have attempted to integrate chemical reactions with detection such as 5 M.A. Burns, et al., "An integrated nanoliter DNA analysis device," Science, 282, pp. 484 487, 1998; S.C. Jacobson and J.M. Ramsey, "Integrated microdevice.for DNA restriction fragment analysis," Anal. Chem., 68, pp. 720-723, 1996; L.C. Waters, et al., "Microchip device for cell lysis, multiplex PCR amplification, and electrophoretic sizing," Anal. Chem., 70, pp. 158-162, 1998; and A.T. Woolley, et al., "Functional integration of PCR 10 amplification and capillary electrophoresis in a microfabricated DNA analysis device," Anal. Chem., 68, pp. 4081-4086, 1996. Generally, as is understandable from the forgoing examples, systems and methods have been described that do not fully provide for a completely integrated self-contained sample to answer system that uses electronically active microchips. Moreover, numerous of 15 the described systems are extremely labor and time intensive requiring multiple steps and human intervention either during the process or between processes which together are suboptimal allowing for loss of sample, contamination, and operator error. Further, the use of multiple processing steps using multiple machines or complicated robotic systems for performing the individual processes is often prohibitive except for the largest laboratories, 20 both in terms of the expense and physical space requirements. For the reasons stated above, these techniques are limited and lacking. They are not easily combined to form a system that can carry out a complete self-contained integrated diagnostic assay, particularly assays for data retrieval for nucleic acids and protein-derived information, on a single electronically addressable microchip. Despite the long-recognized need for such an integrated system 25 without a complicated fluidics and inadequate valve systems, no satisfactory solution has previously been proposed. There is therefore a continuing need for methods and devices which lead to improved dielectrophoretic separation of biological cells as well as improved biological stability of the separated cells and further a continuing need for methods and devices which improve cell preparation and analysis, and which are capable of integrating 30 cell separation, preparation, purification, and analysis in a single self-contained system without complicated fluidics.
WO 00/37163 PCTIUS99/31098 7 SUMMARY OF THE INVENTION Accordingly, provided herein is an integrated, portable system and device for performing active, integrated multi-step sample preparation and molecular diagnostic analysis of biological samples using a minimal number of electronically addressable 5 microchips. In a preferred embodiment, the system and device has a single flow cell element for carrying out the separation, preparation, and analysis of preselected eukaryotic and/or prokaryotic cells from a mixed population of cells. This single flow cell element includes therein an electronically addressable microchip having a grid of individual electrodes. The 10 grid can contain any number of individual electrodes and be fabricated on a silicon wafer as is well understood in the electronic arts. Generally, such a grid can comprise anywhere from 4 to 25 to 100 or even 10,000 or more individual electrodes. This single flow cell embodiment contemplates that the flow cell encompassing the electronic grid is able to achieve simple fluidic manipulation of the cells for their respective separation, lysis, 15 clean-up of cell-derived materials of interest, and analysis of such materials. Preselected eukaryotic and prokaryotic cells may be any type (e.g., blood cells, cancer cells, stem cells, bacteria, etc.) and obtained from any source (e.g., animal, biopsy, blood, organs, forensic samples, stool, water, etc.). Specific examples of cells that can be separated from, for example, whole blood include Escherichia coli, Salmonella typhimurium, 20 Staphylococuus epidermus, Micrococcus lysodeikticus, and cultured cervical carcinoma cells. In an alternative embodiment, the device of the invention may include at least one additional flow chamber for carrying out either a variety of sample preparation steps or for analysis of prepared sample. For example, in one alternative embodiment, the system 25 comprises a first and second flow cell chambers each having an electronically addressable microchip. In this alternative embodiment, the first chamber may be used to separate and lyse cells as well as perform sample preparation steps, while the second chamber is used to analyze the sample materials directly on the second flow cell microchip. In another alternative embodiment comprising at least two flow cells, the first flow 30 cell has no electronically addressable grid but does have at least a heating element attached thereto that can be used to adjust the temperature of materials within said cell. The second flow cell is contemplated to have an electronically addressable microarray for WO 00/37163 PCT/US99/31098 8 use in performing analysis of the sample materials. Regardless of the embodiment utilized, the system of the invention provides the ability to (1) separate eukaryotic cell types from one another as well as eukaryotic cell types from prokarotic cell types, (2) directly process the sample materials from a crude 5 state to a more refined state, and (3) directly analyze the sample materials on the microchip grid. Such an ability is possible by the novel use of electronic biasing at one level of voltage in the form of a dielectric current to cause dielectrophoresis of cells, followed by an increase in voltage to lyse captured cells, followed in turn by changing the manner of biasing from an alternating current mode to direct current mode for the 10 addressing of specific electrodes on the arrays of the flow cell(s) to cause the transport of molecules of interest for capture/hybridization to probes previously bound to the electrode array. The system of the invention further contemplates that other appropriate sample preparation reagents may be transported to and away from the flow cell(s) by simplified arrangement of tubing and solenoid operated valves and pump. Additionally, in 15 embodiments having a first flow chamber that is without a microchip, the system contemplates the ability to directly lyse the cells in the sample and analyze materials of interest without a need for separating the cell types. In such embodiment, the flow cell has a heating element that can be used to raise the temperature for direct lysis of the cells in the sample. Following such lysis, sample preparation steps such as protease treatment or 20 nucleic acid amplification may be performed followed by transporting the amplified species to the second flow cell containing the electronically addressable microchip. In another embodiment, the integrated system contemplates the direct processing of cells selectively separated or lysed in the first chamber to obtain any materials of interest from such cells. Such processing is generally directed to the isolation and 25 purification of proteins and nucleic acids from cellular contaminants. Numerous techniques can be performed in the preparation of molecules of interest including, but not limited to, enzymatic treatment using protease K to remove proteinaceous materials from nucleic acids of interest, enzymatic treatment using nucleases to remove nucleic acids from proteins, digestive residue adsorption, nucleic acid amplification (e.g., by PCR and 30 SDA), in situ buffer exchange and binding of antibodies or other protein-protein binding reactions such as receptor-ligand or enzyme-substrate for binding to proteins of interest. In another embodiment, analysis of prepared sample materials can comprise any WO 00/37163 PCT/US99/31098 9 number of preselected hybridization formats. In a preferred format, nucleic acids of interest are hybridized selectively through an electronically directed process as is known to those skilled in the art of electronically addressable microchips. Such hybridization formats comprise binding of nucleic acids (RNA, DNA, pNA) to probes anchored to the 5 microarray. Other formats contemplated for use with the system include selective capture of proteins of interest such as by antibody or other protein binding probes attached to the electronic grid. These can include other protein-protein interactions such as receptor ligand and enzyme-substrate binding. In still other embodiments, the device contemplates elements (e.g. buffer vials, 10 tubing, miniature solenoid valves, and at least one pump) for carrying and transporting samples, buffers, enzymes and reagents to and from said flow cell(s). Additionally, yet other embodiments are provided for detecting the analytes and molecules of interest being assayed. In a preferred embodiment, such elements include a battery operated diode laser (preferably having a wavelength of 635 nm), and a CCD camera coupled with filters and 15 zoom lens for astronomy of the individual electrodes of the microchip grid(s) of the first and/or second flow cell chamber(s). Still other methods of detection are also contemplated not requiring illumination with a light emitting device such as direct electrochemical detection as is well known by those in the art of such detection as described in P. Ropp and H.Holden Thorp, Chemistry & Biology, 1999, Vol. 6, No.9, pp. 20 599-605. Each of these electronic components are further contemplated to be coordinated through a computer and appropriate programming software as is well understood by those skilled in the electronic arts. BRIEF DESCRIPTION OF THE DRAWINGS 25 The file of this patent contains at least one drawing executed in color. Copies of this patent with color drawing(s) will be provided by the Patent and Trademark Office upon request and payment of the necessary fee. The invention will be further described with reference to the accompanying drawings in which: Figure 1 is a simplified flow chart of the system showing three basic stages of the 30 system including sample preparation, chemical reaction and analyte detection. Figure 2 is a schematic showing the simple overall hardware design of the system wherein there is included a flow chamber 11 with heating element 12, a miniature WO 00/37163 PCT/US99/31098 10 desalting column 13, a laser 14 with optical path 15, and a detector such as a CCD camera 17. Figure 3 is a perspective view showing one example of an external design for the portable system of this invention. The portable system comprises a housing 18 integrated 5 with a computer and monitor 20 via a cable 19. Figure 4 is a an internal view of the integrated system showing various components thereof such as sample and reagent vials 21a-e, heating elements 12, CCD camera 17, laser 14, a series of pumps 46 for each reagent vial, and other features such as a focus adjustment knob 4 and area for electronic components 5. 10 Figure 5 is a cross-section diagram for a flow cell having a microchip grid. The flow cell in total comprises a microchip grid 23 on the inner bottom surface of the flow cell chamber 29. The flow cell is covered by a quartz window 28. The underside of the microchip substrate has attached thereto a heating element 12. The flow cell has at least two inlet ports 30. 15 Figure 6 is a schematic showing an alternative embodiment having two flow cells. In this embodiment, a first flow cell can comprise either a cell having an electronically addressable microchip 31a, or not having such a microchip 31b. In either case, flow cell 31a,b has attached thereto a heating element 12. In this embodiment, the second flow cell 32 has an electronically addressable microchip attached to a heating element 12. As with 20 the preferred embodiment diagramed in Fig. 2, the integrated system further includes a desalting column 13, laser 14 with light path 15, and a detector 17 positioned on a movable track 33 for positioning the detector for astronomy of either flow cell. Figure 7 is a schematic showing a two flow chamber embodiment wherein first 31a and second 32 flow cells are arranged adjacent to one another. Also depicted are flow 25 systems for channeling buffers, reagents, and analytes through the flow cells and desalting column of the system. Figure 8 shows bias pattern formats that can be used to create a pattern of dielectric force for separation of eukaryotic or prokaryotic cells. In (A) is depicted a square-wall dielectric force pattern. In (B) is depicted a checkerboard force pattern. 30 Figures 9 and 10 show two computer representations of dielectric field distributions corresponding to either a square-wall or a checkerboard force pattern respectively.
WO 00/37163 PCT/US99/31098 11 Figure 11 shows a photograph of an electronically addressable microarray in a flow cell during cell separation. The photo specifically depicts a bacterial species being separated from whole blood using a checkerboard dielectric force pattern applied to the electrode of the flow chamber. The bacteria are the light colored concentrations at the 5 field charge maximums directly above the electrodes of the array while the blood cells are in between the electrodes at the field charge minimum areas. Figures 12, 13A and 13B show a eukaryotic cells (cultured HeLa cells) being separated from blood cells (Fig. 12) and after washing (Fig. 13A) and staining with propidium iodide (Fig. 13B). The mixture of the normal human white and red blood cells 10 was pushed to the space between the electrodes where the field was minimum as reflected by the pinkish diamond-shaped spot (Fig. 12). Figures 14-17 show a series of photographs where bacteria cells are separated from blood cells using either a square-wall or checkerboard dielectric field pattern. Figs. 14 and 15 show such separation for square-wall and checkerboard patterns respectively. Figs. 16 15 and 17 show separated bacteria after washing square-wall and checkerboard patterns respectively. Figure 18 is a photo of a PAGE showing analysis of nucleic acids released from bacteria by electronic lysis. Lanes I and 6 are markers, lanes 4 and 5 are whole bacteria DNA with and without Rnase treatment respectively, and lanes 2 and 3 are supercoiled 20 and linear plasmid pCR2.1 DNA released from the bacteria. Figures 19 and 20 are PAGE photos showing amplification of two S. enterica genes spa Q and inv A, by SDA in the flow cell of the invention. In Fig. 19, from left to right, lanes 1 and 6 are size markers, lanes 2 and 3 are negative and positive controls respectively, lane 5 is the result of an amplification of inv A gene specific DNA sequence 25 amplified using the device of the invention. In Fig. 20 lane 2 is a marker, lanes 1 and 4 are positive and negative controls respectively, and lane 3 is the amplification result for the spa Q gene. Figure 21 is a photo showing hybridization results for spa Q gene wherein two electrode pads equipped with specific probe for spa Q gene were tested for hybridization 30 in duplicate, a third pad specific for the gene was hybridized with amplified material from a positive tube reaction, and a fourth pad which was equipped with a nonspecific probe was tested for hybridization to amplification product produced in the flow cell.
WO 00/37163 PCT/US99/31098 12 Figure 22 is a photo showing amplified spa Q gene products addressed to capture sites of electrodes of the microarray using two different biasing conditions. In the top row is duplicate addressing to pads having capture probes specific for spa Q sequence (lanes 3 and 4) while lanes 1 and 5 have nonspecific probes. In the top row, a sinusoidal wave AC 5 format was used while in the bottom row a direct current (DC) format was used. The results indicate that using a DC format is slightly superior to an AC format in transporting nucleic acids to the electrodes as the DC protocol bound a higher degree of amplicon. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS 10 Referring now to specific embodiments of the invention, a portable lab-on-a-chip system is provided wherein a sample may be processed and analyzed in at least a single flow cell comprising an electronically addressable microchip. The elements of the device are housed in a portable casing or housing which contains the sample preparation and analysis flow chamber, fluid handling systems, and illumination source (such as a battery 15 operated 635 nm diode laser) and detection electronics (such as a CCD camera coupled with a set of filters and a zoom lens for astronomy of the microchip). External to the portable casing is a computer, such as a personal computer connected to the portable housing by a cable. Referring now to Fig. 1, a flow chart is shown depicting three distinct sample 20 handling stages for carrying out bioassays as contemplated using the lab-on-a-chip system of the invention. These are: (1) sample processing, (2) chemical reaction, and (3) analyte detection. Sample handling in stage (1) processing generally comprises processing of crude biological samples (e.g., cells from blood, urine, stool, mixed cell populations, etc.) for the 25 purpose of isolating molecules of interest such as nucleic acids and proteins. Sample handling at the chemical reaction stage (2) involves potentially many types of molecular biological reactions for clean-up and further isolation, purification,, or amplification of molecules of interest including, but not limited to, enzymatic-based reactions such a treatment with proteases, nucleases and restriction enzyme digestion, PCR and SDA-based 30 nucleic acid amplification, in situ buffer exchanges, chemical labeling such as by radioisotope and fluorescence markers, and immuno-based and protein-protein reactions such as antibody-antigen, ligand-receptor, and enzyme-substrate reactions. Sample WO 00/37163 PCT/US99/31098 13 handling at the analyte detection stage (3) may be accomplished through numerous formats including optical detection of fluorescent emissions, electrochemical detection, and radioisotope detection. In a preferred embodiment, this detection comprises hybridization of nucleic acids or captured proteins to the electronic grid and detection 5 using fluorescent imaging. In Figure 2, the system is depicted in schematic form showing a top-down or edgewise view of the basic components. In this diagram a support 10 is used to mount the flow cell 11. On the backside of the flow cell 11 mounted to the support is a heating element 12. Additionally, the flow cell may be connected via a hollow fiber to ports and 10 to a desalting column 13 in order to purify, desalt and introduce different buffers into the flow stream. The heating element may be used to heat the flow cell for either direct heat induced lysis of cells in the chamber or for use in stage 2 process reactions such as inhibiting enzymes and temperature cycling for nucleic acid amplification. As will be understood by one of skill in the art, the flow cell, as well as the other 15 electrically operated components, such as solenoid operated valves and pumps, laser and detection camera, are interconnected electronically with the computer. 20 by cabling 19 to the housing 18 for all programming and control purposes. By way of example, the power source and computer are connected to the electrodes of the flow cell 11 for programming and manipulation. In the preferred embodiment, the electronic signals that may be 20 generated by the computer software used with the system include an AC component, such as where the AC component is sinusoidal and used in dielectrophoresis, and such as where a DC component is square and used in hybridization. In yet a further aspect, it is preferred that a time varying electronic signal also used in the system includes an offset signal, such as where the offset signal is a DC signal. 25 Figure 2 further shows illumination source 14 that emits a laser beam 15. Preferably, the illumination source 14 is a diode laser. The beam 15 is preferably incident on a beam splitter 16 that directs at least a portion of the beam 15 towards the flow cell 11 microchip for sample analysis. Radiation emitted from the microchip grid electrodes retraces the incident path, and at least a portion of that radiation is passed through the 30 beam splitter 16 to detector 17. In the preferred embodiment, the detector 17 comprises a charged coupled device (CCD) detector. Alternatively, other detectors may be utilized.
WO 00/37163 PCT/US99/31098 14 However, for compactness, it is preferred to have a detector which generally has relatively larger area coverage compared to its depth (in the direction of the emitted radiation). Figure 3 shows a perspective view of one design or style for the overall portable, integrated lab-on-a-chip system. A computer 20, preferably a portable notebook personal 5 computer, includes conventional elements such as a keyboard, function keys, a monitor, and input devices, e.g., trackball, and mouse. Housing 18 serves to contain not only the preparation, reaction, and analysis platforms comprising the flow cell, but also additional equipment utilized in conjunction with computer 20 for operation of the system. For example, housing 18 may contain (Fig. 4) a power supply, waveform generator, laser, flow 10 cell(s), CCD camera, and other electronics, fluidic systems, and reagents required for operation and control of the system. As an example of a flow cell design, Figure 5 shows a cross-section of such a cell. An electronically addressable microarray 23 is mounted onto substrate 10 containing a 1.0 inch square pin grid array (PGA) (068 PPGA, 400 Square Cavity, Spectrum 15 Semiconductor Materials, San Jose, CA). Attached to the back side of the substrate 10 is a ceramic chip heater element 12 (Dawn 505, Dawn Electronics, Carson City, Nevada). The heating element 12 may be attached by any number of methods. In a preferred embodiment, the attachment may be achieved by placing a thermally conductive flexible adhesive 22 between the backside of the electronic microchip and the ceramic heater and 20 then incubating at an appropriate temperature and time to fix the adhesive. Additionally, as is well understood in the art, these microchips are coated with a thin permeation layer 25 such as a hydrogel, agarose, a polymer of acrylamide, or a sol-gel matrix or the like. This permeation layer 25 protects the cells and molecules of interest (i.e., biomaterials) from the electrochemistry occurring at the electrode surface that would otherwise damage 25 the biomaterials (or the ability to assay them) if they were exposed directly to the electrodes. The microchip can be then attached to a molded or machined medical grade plastic flow cell 27 so that the electronic microarray 23 makes up the inner bottom surface of a well within the flow chamber. The flow cell 27 provides a compartment 29 for containing 30 biological sample materials and buffers to be layered on top of the microchip. The flow cell may be further designed to have at least 2 to 4 ports 30 for sample delivery and extraction. The flow cell 27 may further be constructed so as to accept tubing for WO 00/37163 PCT/US99/31098 15 interfacing with exterior fluidic delivery and removal systems as well as desalting. Additionally, the flow cell compartment is covered and sealed by a fused quartz window or lid 28 for visual access to the microarray analysis sites or capture pads. This window 28 can comprise any thickness of quartz but generally is about 0.015 inches thick. 5 The window 28 may be attached to the flow cell and the flow cell to the chip by any number of methods of which a preferred method uses. an ultraviolet (UV) curing adhesive 26 developed for optics assembly. Attachment of the flow cell to the chip may be either directly to a bare surface of the chip or to the permeation layer overlaying the microarray also using adhesive 26. Tubing is attached to the inlet and outlet ports using a 10 variety of methods depending on the tubing size, fittings, and the tubing base material. In an alternative embodiment, the integrated system may use two flow cells, one for sample preparation and the second for analysis. Figure 6 shows in schematic form such an embodiment. The first flow chamber 31 is attached to a heating element 12 and may optionally have an electronically addressable microchip 31a or no such microchip 15 31b. In either format, i.e., with or without electronic microchip, the flow cell 31 is used to perform in a stepwise fashion cell separation and/or cell lysis, and clean-up and further preparation of molecules of interest recovered from the lysed cells. Further preparation of molecules of interest is contemplated to include any number of chemical reactions and steps as stated above such as isolating specific proteins of interest, isolating nucleic acids 20 of interest such as by treatment with proteases to remove proteinaceous material from the nucleic acids, and amplification of nucleic acids of interest such as by PCR and SDA. The second flow cell 32 is used for sample analysis. In a preferred embodiment both flow cells 31 and 32 are disposed on the same side of the support 10. However, these flow cells may be disposed in alternative arrangements, including a back-to-back or a 25 stacked configuration. Additionally, these two flow cells may be connected via a hollow fiber in order to purify, desalt and introduce different buffers into the flow stream. Moreover, each flow cell may be designed to have independent temperature control elements as desired. As will be understood by one of skill in the art, each of the electronically addressable microchips within the flow cells, as well as the other electrically 30 operated components, such as solenoid operated valves and pumps, are interconnected electronically with the computer 20 by cabling for all programming and control purposes as in the single flow cell arrangement.
WO 00/37163 PCT/US99/31098 16 Figure 6 further shows illumination source 14 that emits a laser beam 15 and operates in the same fashion as described above. A camera with zoom lens 17 for astronomy of the electronic grids of the flow cells is also incorporated on a movable track 33 so that both the first and second flow cell electronic microarray grids can be viewed. 5 Figure 7 is a schematic of the alternate system showing support 10 including the flow cells for sample preparation 31a (shown as an electrode comprising flow cell) and analysis 32 (shown as a 25 electrode grid). Each of the flow cells preferably include a plurality of ports 42 connected to tubing or hollow fiber 44 leading to electrically operated 3-way valves 45. With respect to the preparation flow cell 31a, the cell is contemplated to 10 possess at least two ports 42, optionally at least three ports, and in the preferred embodiment four ports. With respect to the analysis flow cell 32, this cell preferably has two ports. These ports 42 and their respective tubing 44 may be utilized for various functions at different times. For example, at one time a port may be considered an input port, whereas at another time, it may comprise an output port, based on the directionality 15 of the flow into or out of the flow cells 31 and 32 as directed by the setting of the 3-way valves 45 and directionality of pump 46. Fluids in the chambers may be mixed by "pushing" and "pulling" of the liquids in various sequences through the ports. Such mixing may be advantageous, for example, during an amplification procedure. Figure 7 further depicts other components of the self-contained system. In one 20 embodiment, receptacles 21a-e provide for carrying samples and reagents such as for washing, amplification, hybridization, and waste. In another embodiment, the support 10 has attached thereto a miniature desalting column or a hollow fiber ion-exchange unit 13 for desalting small sample volumes. Often, there is a need to perform a desalting step to lower the ionic strength of the sample prior to attempting to electronically address 25 amplified nucleic acids to specific capture pads of the microarray. This is because reagents used in amplification steps have an ionic strength that interferes with the migration of molecules of interest under the electronic addressing protocols. Once the amplified sample has been desalted it can be directed to the flow cell 32 for analysis on the microarray. 30 Whether using a single or multiple flow cell integrated system of the invention, cell separation is achieved by a dielectrophoresis technique. In such method, polarizeable WO 00/37163 PCT/US99/31098 17 particles (e.g., eukaryotic and prokaryotic cells) including those with no net charge are subject to a "dielectrophoretic" force of a non-uniform electrical field. As long as the effective polarizability of the particles is different from that of the surrounding medium, the cells will remain subject to the dielectric force. The direction of migration of different 5 cell types is determined by: (1) surface charges of the cell walls or membranes of the cell bilipid membranes, (2) the conductivity and permitivity of such cell membranes and walls, and (3) the morphologies and structural architectures of the cells. Dielectrophoresis as practiced in the current invention has been used to selectively separate from mixed cell populations (e.g., blood cells) several types of bacteria including Escherichia coli, 10 Salmonella typhimurium, Micrococcus lysodeikticus and Staphylococcus epidermidis as well as cancer cells such as cultured cervical carcinoma cells. In a preferred embodiment, a flow cell useful for separating cells as practiced in this invention may be designed to include an electronically addressable microchip having at least 100 individually addressable microelectrodes capable of being biased individually 15 so that a dielectric force pattern may be generated across the microchip electronic grid. For example, Fig. 8 shows two such force patterns. In Fig. 8A is a square-wall pattern while 8B shows a checkerboard pattern. Each of these patterns provide a unique strong and weak ionic field strength pattern that provides dielectric force sufficient to separate different cell types. The force pattern is further depicted in computer generated field 20 patterns shown in Figs. 9 and 10 for square-wall and checkerboard respectively. Additionally, the electrodes of the microarray in the flow cell(s) may be biased either all together as a single array for carrying out cell separation, lysis, and analysis, or may be programmed to form subarrays in any number of patterns for carrying out the separation, lysis, and analysis steps. In other words, one subset may be biased to separate 25 cells, another set may be biased to cause cell lysis, and yet another set may be used for analysis. In an example of cell separation, Figure 11 shows the separation of Micrococcus lysodeikticus from whole blood. The bacteria are concentrated above the electrodes while the undesired blood cells, both red and white cells, are dark areas in between the 30 electrodes. The cells were made to separate using a protocol of biasing comprising a sinusoidal signal of 10 V peak-to-peak at 10 kHz. Although this signal value was used in WO 00/37163 PCT/US99/31098 18 this instance, generally cell separation can be carried out using sinusoidal signals wherein the Volts are between 2 and 20 peak-to-peak while frequencies are between 5 and 50 kHz. Undesired cells are washed from the flow chamber while retaining the cells of interest. This is accomplished by maintaining an attractive bias for the cells of interest 5 and creating a flow of wash buffer through the flow chamber. Once the cells of interest are isolated in the flow chamber they may be treated in any number of ways for further processing. In one embodiment, the cells are lysed by applying high voltage pulses of up to 450 volts with a pulse width between 10 ts and 50 pts as described in J. Cheng, et al., "Preparation and hybridization analysis of DNA/RNA from E. coli on microfabricated 10 bioelectronic chips," Nature Biotechnol., 16, pp. 541-546, 1998. In another example, . coli cells were separated from blood cells as shown in Figures 14-17. In Figure 14 a square-wall dielectric force pattern was used while in Fig. 15, a checkerboard pattern was used. As an example, the separation for the checkerboard pattern used a bias format of a sinusoidal signal of 10 V peak-to-peak at 10 kHz. Figures 16 and 17 show how cleanly 15 the bacterial cells were isolated following washing of the square-wall and checkerboard patterned separation. In another example, mammalian cells are separated on the electronic grid of the flow chamber. Figures 12, 13A and 13B show separation of cervical carcinoma cells. Fig. 12 shows initial separation wherein the cells move onto the electrodes of the grid 20 where the field is at a maximum by subjecting the cells to,a positive dielectrophoretic force. The mixture of the normal human white and red blood cells mixed with the carcinoma cells are pushed to the space between the electrodes where the field was minimum as reflected by the pinkish diamond-shaped spots. After washing, the carcinoma cells were retained by the electrodes (Fig. 13A) whereas all of the normal blood 25 cells were washed out. Figure 13B shows the cells after staining with propidium iodide. As an example, the mammalian cells could be separated using the checkerboard format and applying a sinusoidal signal of 6 V peak-to-peak at 30 kHz for 3 minutes. J. Cheng, et al., "Isolation of Cultured Cervical Carcinoma Cells Mixed With Peripheral Blood Cells on a Bioelectronic Chip," Anal. Chem. v.70, pp 2 3 2 1-26, 1998. 30 Following lysis, both cellular proteins and nucleic .acids may be retained for analysis. An example showing that nucleic acid may be retained from lysed cells is WO 00/37163 PCTIUS99/31098 19 provided in Figure 18. There, E coli DNA is run on a PAGE gel showing both chromosomal and plasmid DNA is retained. Where nucleic acids are desired for analysis, further clean-up and purification may include treatment with proteases such as with Proteinase K. After such treatment, the 5 lysate may either be analysed immediately, or amplified then analysed. If the alternate embodiment is used, the sample may be further treated in the flow 'chamber or may be exported to the second chamber for such protease treatment, amplification and analysis. Generally, a protease treatment may be carried out in an appropriate buffer at 60'C for 15 min. Temperature control may be achieved by use of the ceramic heater element attached 10 to the back of the microchip. Inactivation of proteinase K may be achieved by heating the sample at 95'C for 2 min. Overall, the cell separation, lysis, and protease treatment process can take between 15-25 minutes. Where proteins are desired, nucleic acids may be removed by treating the sample with restriction enzymes and nucleases. The proteins may further be treated with various 15 enzymes and partial protease treatments to release specific proteins of interest from cell membranes and other cellular components. Following the above sample processing steps additional processing may be carried out including amplification (e.g., by PCR and SDA) and labeling with radioisotopic or fluorescent markers. In an example of chemical reaction stage processing, specific nucleic acid 20 sequences, (i.e., the invA and spa Q genes of Salmonella enterica) were amplified using SDA. SDA is preferred in this portable system as the amplification may be performed under isothermal conditions at between 50'C and 60*C thereby eliminating high temperature denaturation cycles associated with PCR. However, in one embodiment, the portable system is capable of performing PCR amplification as the flow chamber is 25 equipped with the aforementioned heating element that has the capability of achieving repetitive high temperature cycling. As shown in Figures 19 and 20 SDA can be effectively performed in the device with a product yield comparable to the positive control performed in a conventional reaction tube. In this example in a volume of 50 [1, Salmonella enterica and blood cells 30 were mixed and injected into the flow cell containing a 10,000 site electrode array. The bacterial cells were separated from the blood cells by dielectrophoresis using a biasing WO 00/37163 PCT/US99/31098 20 protocol of a 1 OV peak-to-peak signal having a sinusoidal wave form with frequency of between 10 and 15 kHz using the checkerboard pattern. The cell mixture was pumped into the flow cell at a rate of 31 tl per minute until the flow chamber was filled, then the flow rate was adjusted to 12.4 pl/min until the total 50 ptl volume was passed through the 5 chamber. The cells were retained above the electrodes by influence of the positive dielectrophoretic force established by the protocol. The flow cell was then washed with water to remove cells not retained by the positive bias by pumping buffer in a reverse direction at a rate of 114 pl/min for 10 minutes. The fluid content of the flow cell was then exchanged with a solution of SDA reagents for amplifying either the spa Q or inv A gene 10 sequences. The total nucleic acid from the bacteria cells was isolated by first lysing the cells by energizing the electrodes with pulsed direct current at 200 V having a square wave form af 10 ms duration and a total of 40 separate pulses. (Alternatively, the cells can be lysed by heating the chamber to 95'C for five minutes). A concentrated SDA reagent and 15 buffer stock mix was introduced into the flow cell and mixed with the denatured target nucleic acid to give the following final concentrations of SDA reaction components: 500 nM amplification primers, 50 nM 'bumper' primers, 9.5 mM magnesium acetate, 35 mM potassium phosphate buffer pH 7.6, 80 pg/ml bovine serum albumin, and 1.4 mM each of dATP, dGTP, TTP, and alpha-thiolated dCTP. The amplification primers were designed to 20 amplify 81 base pairs of the invA or spa Q gene and comprised the following nucleic acid sequences: spa Q Seq. Id. No. 1 5'-accgcatcgaatgcatgtetcgggtcctggtagggttattc- 3 ' spa Q Seq. Id. No. 2 5'-cgattccgctccagacttctcgggaacacacgccaagta- 3 ' inv A Seq. Id. No. 3 5' -accgcategaatgcatgtctcgggtttcaacgtttcctgeg- 3 ' 25 inv A Seq. Id. No. 4 5'-cgattccgctccagacttctcgggatcgataatgccagacg- 3 ' Bumper primers comprised the following sequences: spa Q Seq. Id. No. 5 5'-gcaacgattatcggc-3' spa Q Seq. Id. No. 6 5'-ccagacagtaaaaac-3' inv A Seq. Id. No. 7 5'-ttgacagaatcctca-3' 30 inv A Seq. Id. No. 8 5'-taagacggctggta-3' WO 00/37163 PCT/US99/31098 21 The released nucleic acid was then denatured by heating the chamber to 90 0 C for five minutes. The chamber was then brought to 60 0 C and 10 pl of SDA reagent buffer containing enzymes was introduced into the chamber to initiate amplification (i.e., 40 units of BsoB I restriction endonuclease and 16 units of exo-Bst DNA polymerase). 5 In the system of the invention, amplification using SDA may be carried out for between 25 and 35 minutes. In the present example, after 30 minutes of reaction a 5 p1 aliquot of the reaction volume was removed for PAGE analysis (Figs. 19 and 20). The third stage of sample handling comprising detection of the molecules of 10 interest is preferably carried out for proteins and nucleic acids of interest. Such detection can use various forms of hybridization to probes previously' attached to the microarray. For example, nucleic acids (e.g., RNA, DNA, and pNA) may be used for binding sample derived nucleic acid analyte (e.g., amplified or unamplified target nucleic acids) by hybridization. Proteins may also be made to bind to capture molecules (i.e., protien-ligand 15 binding interactions) attached to the array. Such capture molecules may comprise proteins or other molecules and the binding interaction can comprise such interactions as antigen antibody, enzyme-substrate, and receptor-ligand binding. With respect to nucleic acids, target species, whether amplified or not, are electronically addressed to specified capture pads of the microarray of either the single (or 20 the secondary) flow chamber for capture by oligonucleotide probes that are anchored thereto. Preferably, the electrode array of the flow cell, (i.e., flow cell 11, 31a or 32 depending upon the embodiment and protocol used) has at least 25 individually addressable electrodes coated with a permeation layer (e.g. for example, an acrylamide based hydro-gel). The target nucleic acid is biased using a positive sinusoidal signal 25 generated using a function generator/arbitrary wave form generator (33120A, Hewlett Packard, Santa Clara, CA). The capture probe-target hybrids are then detected using fluorophore-labeled reporter probes and the CCD-based optical imaging system employed for the portable instrument shown in Figure 2. Detection with this arrangement takes approximately 5 min to accomplish. 30 Continuing with the above example, the amplification products of the spa Q and inv A genes were available for capture and analysis. Prior t6 capture, the SDA reaction WO 00/37163 PCTIUS99/31098 22 solution and amplification products were passed through a desalting column in a volume of about 75 ul followed by exchanging the buffer with a 50 mM Histidine buffer. The amplification products were then addressed to specific pads of the electrodes which contained gene specific probes attached to the permeation layer overlaying the electrodes. 5 This was followed by washing the chamber with 200mM NaCl, 10 mM Tris pH 8.0, 1 mMEDTA, followed in turn by introduction of a bodipy 630-labeled probe oligonucleotide specific for the amplification product at a concentration of 0.5 LM in 200 mM NaCl, 10 mM Tris pH 8.0, 1 mM EDTA, and 100 ug/ml Calf Thymus DNA. The reporter probe solution was left in the assay cell for 10 minutes then washed with 7 - 800 10 1 A of 50 mM Histidine buffer. The chamber was then visualized using a 630 nM helium neon laser and a computer controlled CCD camera. Figure 21 shows results of binding of the spa Q gene amplification product to individual pads of the electrode in the flow chamber. The binding shows that the amplification product produced in the flow cell annealed to the capture pads (fraction I and 2) satisfactorily in comparison to annealing of 15 amplification product produced as a control in a reaction tube and then introduced into the flow cell chamber after the fractions I and 2 had been addressed. The level of binding for the control amplified product is higher due to the higher level of amplification obtained in the control reaction. We note that very little nonspecific binding of amplified product from the flow cell reaction bound to a capture site having a nonspecific capture probe. 20 In Figure 22, the amplified SDA products for the spa Q gene were also addressed to specific pads on the microarray using two alternate biasing formats. In one biasing protocol, the amplicons were addressed using a sinusoidally based AC format of 3.5 V peak-to-peak at 1 kHz. This protocol also used a DC offset voltage of +2.3 V for 5 minutes. In the other protocol, a direct current (DC) format was used comprising +2.5 V 25 for 2 minutes. As can be seen, the DC protocol is able to transport the molecules of interest to the capture sites with greater efficiency as the DC biased pads exhibit a greater binding signal. This result further shows the versatility of the system in that processing of sample materials (cells and molecules) may be manipulated in a wide range of adjustments that is possible using this electronic-based lab-on-a-chip system. For example, the use of 30 an AC format though shown in the above example as providing less transport mobility to the specific sequence, can be performed where the voltage range is between 2.0 and 5.0 WO 00/37163 PCT/US99/31098 23 peak-to-peak, the frequency range is between I and 10 kHz, and the DC offset is in a range of 1-5 volts). This versatility of ranges provides for transport of molecules under variable buffer conditions. Visual detection of amplification reaction products by probe hybridization may be 5 performed by directing a battery operated diode laser having at least the capability of generating approximately 2 mWatts of laser power with an emission wavelength of 635 nm. The laser is used to excite fluorescent dye-label reporter probe (such as BODIPY 630). The wavelength of the emission filter is 670 nm. The dichromatic mirror has a wavelength cutoff at 645nm. Alternatively, a direct electrochemical voltammetric 10 detection system may also be used instead of light based detection as is understood by those skilled in the art. Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity and understanding, it will be readily 15 apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims.
Claims (139)
1. An integrated system for the analysis of eukaroytic and/or prokaryotic cells in a biological sample comprising: a. an electronic system for cell separation, cell lysis, sample preparation, and 5 sample analysis further comprising: at least one input and at least one output port connected to a flow cell, a plurality of individually addressable electrodes positioned within said flow cell, and a heating element connected to said flow cell, said flow cell adapted to receive said sample via the input, said electrodes being 10 operatively coupled to a power source adapted to electronically disrupt cell membranes within said sample, said electrodes further comprising an active matrix array adapted to bind to predetermined molecules of interest within said sample for analysis of said molecules; b. a detector operatively positioned to detect said molecules bound to 15 said active matrix array by a detectable signal; and c. a power source.
2. An integrated system of claim 1 wherein the sample preparation further includes the step of cell separation. 20
3. An integrated system of claim 2 wherein the cell separation is performed electronically.
4. An integrated system of claim I further comprising an illumination source 25 operatively positioned to provide radiation to the active matrix array.
5. An integrated system of claim 4 wherein the illumination source is a laser.
6. An integrated system of claim 5 wherein the laser is a diode laser. 30
7. An integrated system of claim 5 wherein the system includes a beam splitter. WO 00/37163 PCT/US99/31098 25
8. An integrated system of claim 7 wherein the beam splitter is positioned to receive the illumination and reflect at least a portion thereof to the active matrix array, and to pass at least a portion of the radiation from the active matrix array. 5
9. An integrated system of claim 1 wherein said plurality of individually addressable electrodes comprising the active matrix array are used as a unit for each of said cell separation, cell lysis, and sample analysis.
10. An integrated system of claim I wherein said plurality of individually 10 addressable electrodes comprising the active matrix array are used independent of one another in the formation of subsets of electrodes for cell separation, cell lysis, and sample analysis.
11. An integrated system of claim I wherein the sample preparation includes 15 further reaction steps after said electronic lysis.
12. An integrated system of claim 11 wherein the further reaction includes enzymatic reaction. 20
13. An integrated system of claim 11 wherein the further reaction includes chemical reaction.
14. An integrated system of claim I1 wherein the further reaction includes protease reactions. 25
15. An integrated system of claim 14 wherein the protease reaction includes protease-K reaction.
16. An integrated system of claim 1 wherein the further reaction includes an 30 amplification reaction.
17. An integrated system of claim 16 wherein the amplification includes SDA. WO 00/37163 PCT/US99/31098 26
18. An integrated system of claim 16 wherein the amplification includes PCR.
19. An integrated system of claim 16 wherein the amplification includes linear 5 amplification.
20. An integrated system of claim 16 wherein the amplification includes exponential amplification. 10
21. An integrated system of claim 1 wherein the power source provides a time varying signal to at least certain of the electrodes.
22. An integrated system of claim 21 wherein the time varying signal includes an AC component. 15
23. An integrated system of claim 22 wherein the AC component is sinusoidal.
24. An integrated system of claim 21 wherein the time varying signal includes an offset signal. 20
25. An integrated system of claim 24 wherein the offset is a DC offset.
26. An integrated system of claim I further including a control system. 25
27. An integrated system of claim 26 wherein the control system is a computer.
28. An integrated system of claim 27 wherein the computer is a personal computer. 30
29. An integrated system of claim 28 wherein the personal computer is a notebook computer. WO 00/37163 PCT/US99/31098 27
30. An integrated system of claim I wherein the flow cell of the electronic system includes at least one port in addition to the input and the output ports.
31. An integrated system of claim 30 wherein the flow cell of the electronic 5 system includes at least two ports in addition to the input and the output ports.
32. An integrated system of claim 31 wherein the ports are at substantially 90 degrees to another port. 10
33. An integrated system of claim 30 wherein at least two of the ports are in opposition to one another.
34. An integrated system of claim I wherein the detector is a CCD detector. 15
35. An integrated system of claim I wherein the system is a closed system.
36. An integrated system of claim 1 wherein the system is a self contained system. 20
37. An integrated system of claim I wherein the system further includes a fluidic system.
38. An integrated system of claim 37 wherein the fluidic system includes a pump. 25
39. An integrated system of claim 37 wherein the fluidic system includes a plurality of valves.
40. An integrated system of claim 1 wherein the sample analysis includes 30 binding of molecules to the array selected from the group consisting of hybridization and protein-ligand binding interactions. WO 00/37163 PCT/US99/31098 28
41. An integrated system of claim 40 wherein the hybridization is DNA-DNA hybridization.
42. An integrated system of claim 40 wherein the -hybridization is DNA/RNA 5 hybridization.
43. An integrated system of claim 40 wherein the hybridization is pNA/nucleic acid hybridization. 10
44. An integrated system of claim 40 wherein the protein-ligand binding is selected from the group consisting of receptor-ligand, antigen-antibody, and enzyme substrate binding.
45. An integrated system for the analysis of a biological sample containing 15 eukaroytic and/or prokaryotic cells, comprising: a. a first electronic system for sample preparation, said system further comprising: at least one input port, a first flow cell connected to the input, a plurality of electrodes positioned within said. flow 20 cell, and at least one output port, said flow cell adapted to receive said sample via the input, said electrodes being operatively coupled to a power source adapted to electronically disrupt cell membranes within said sample; b. a second electronic system for sample analysis, said system further 25 comprising: at least one input port, a second flow cell connected to the input, a plurality of electrodes positioned within said second flow cell, said electrodes comprising an active matrix array adapted to bind to predetermined molecules of interest 30 within said sample for analysis of said molecules, and at least one output port, said input of the second electronic WO 00/37163 PCT/US99/31098 29 system being coupled to at least one output port of the first electronic system; c. a detector operatively positioned to detect said molecules bound to said active matrix array by a detectable signal; and 5 d. a power source.
46. An integrated system of claim 45 wherein the sample preparation further includes the step of cell separation. 10
47. An integrated system of claim 46 wherein the cell separation is performed electronically.
48. An integrated system of claim 45 further comprising an illumination source operatively positioned to provide radiation to the active matrix array. 15
49. An integrated system of claim 48 wherein the illumination source is a laser.
50. An integrated system of claim 49 wherein the laser is a diode laser. 20
51. An integrated system of claim 48 wherein the system includes a beam splitter.
52. An integrated system of claim 51 wherein the beam splitter is positioned to receive the illumination and reflect at least a portion thereof to the active matrix array, and 25 to pass at least a portion of the radiation from the active matrix array.
53. An integrated system of claim 45 wherein said plurality of individually addressable electrodes of said first electronic system are used as a unit for each of said cell separation and cell lysis. 30
54. An integrated system of claim 45 wherein said plurality of individually addressable electrodes of said second electronic system are used as a unit for said analysis. WO 00/37163 PCT/US99/31098 30
55. An integrated system of claim 45 wherein said plurality of individually addressable electrodes of said first electronic system are used independent of one another in the formation of subsets of electrodes for cell separation and cell lysis. 5
56. An integrated system of claim 45 wherein said plurality of individually addressable electrodes of said second electronic system are used independent of one another in the formation of subsets of electrodes for said analysis. 10
57. An integrated system of claim 45 wherein the sample preparation includes further reaction steps after said electronic lysis.
58. An integrated system of claim 57 wherein the further reaction includes enzymatic reaction. 15
59. An integrated system of claim 57 wherein the further reaction includes chemical reaction.
60. An integrated system of claim 57 wherein the further reaction includes 20 protease reactions.
61. An integrated system of claim 60 wherein the protease reaction includes protease-K reaction. 25
62. An integrated system of claim 57 wherein the further reaction includes an amplification reaction.
63. An integrated system of claim 62 wherein the amplification includes SDA. 30
64. An integrated system of claim 62 wherein the amplification includes PCR. WO 00/37163 PCT/US99/31098 31
65. An integrated system of claim 62 wherein the amplification includes linear amplification.
66. An integrated system of claim 62 wherein the amplification includes 5 exponential amplification.
67. An integrated system of claim 45 wherein the power source provides a time varying signal to at least certain of the electrodes. 10
68. An integrated system of claim 67 wherein the time varying signal includes an AC component.
69. An integrated system of claim 68 wherein the AC component is sinusoidal. 15
70. An integrated system of claim 67 wherein the time varying signal includes an offset signal.
71. An integrated system of claim 70 wherein the offset is a DC offset. 20
72. An integrated system of claim 45 further including a control system.
73. An integrated system of claim 72 wherein the control system is a computer.
74. An integrated system of claim 73 wherein the computer is a personal 25 computer.
75. An integrated system of claim 74 wherein the personal computer is a notebook computer. 30
76. An integrated system of claim 45 wherein the first flow cell of the first electronic system includes at least one port in addition to the input and the output ports. WO 00/37163 PCT/US99/31098 32
77. An integrated system of claim 76 wherein the first flow cell of the first electronic system includes at least two ports in addition to the input and the output ports.
78. An integrated system of claim 77 wherein the ports are at substantially 90 5 degrees to another port.
79. An integrated system of claim 76 wherein at least two of the ports are in opposition to one another. 10
80. An integrated system of claim 45 further including at least one heater element.
81. An integrated system of claim 80 wherein a heater is disposed on the first electronic system. 15
82. An integrated system of claim 80 wherein a heater is disposed on the second electronic system.
83. An integrated system of claim 80 wherein the heater element is in thermal 20 contact with either of the first or second electronic systems.
84. An integrated system of claim 45 wherein the detector is a CCD detector.
85. An integrated system of claim 45 wherein the system is a closed system. 25
86. An integrated system of claim 45 wherein the system is a self contained system.
87. An integrated system of claim 45 wherein the system further includes a 30 fluidic system. WO 00/37163 PCT/US99/31098 33
88. An integrated system of claim 87 wherein the fluidic system includes a pump.
89. An integrated system of claim 87 wherein the fluidic system includes a 5 plurality of valves.
90. An integrated system of claim 45 wherein the sample analysis includes binding of molecules to the array selected from the group consisting of hybridization and protein-ligand binding interactions. 10
91. An integrated system of claim 90 wherein the hybridization is DNA-DNA hybridization.
92. An integrated system of claim 90 wherein the hybridization is DNA/RNA 15 hybridization.
93. An integrated system of claim 90 wherein the hybridization is pNA/nucleic acid hybridization. 20
94. An integrated of claim 90 wherein the protein-ligand binding is selected from the group consisting of receptor-ligand, antigen-antibody, and enzyme-substrate binding.
95. An integrated system for the analysis of a biological sample containing 25 eukaroytic and/or prokaryotic cells, comprising: a. a first nonelectronic system for sample preparation, said system further comprising: at least one input port, a first flow cell connected to the input, a heater element, and at least one output port, said 30 flow cell adapted to receive said sample via the input, said heater being operatively coupled to a power source adapted WO 00/37163 PCT/US99/31098 34 to heat said flow cell to a temperature sufficient to induce disruption of cell membranes within said sample; b. a second electronic system for sample analysis, said system further comprising: 5 at least one input port, a second flow cell connected to the input, a plurality of electrodes positioned within said second flow cell, said electrodes comprising an active matrix array adapted to bind to predetermined molecules of interest within said sample for analysis of said molecules, and at 10 least one output port, said input of the second electronic system being coupled to at least one output port of the first nonelectronic system; c. a detector operatively positioned to detect said molecules bound to said active matrix array by a detectable signal; and 15 d. a power source.
96. An integrated system of claim 95 further comprising an illumination source operatively positioned to provide radiation to the active matrix array. 20
97. An integrated system of claim 96 wherein the illumination source is a laser.
98. An integrated system of claim 97 wherein the laser is a diode laser.
99. An integrated system of claim 96 wherein the system includes a beam 25 splitter.
100. An integrated system of claim 99 wherein the beam splitter is positioned to receive the illumination and reflect at least a portion thereof to the active matrix array, and to pass at least a portion of the radiation from the active matrix array. 30
101. An integrated system of claim 95 wherein said plurality of individually addressable electrodes of said electronic system are used as a unit for said analysis. WO 00/37163 PCT/US99/31098 35
102. An integrated system of claim 95 wherein said plurality of individually addressable electrodes of said electronic system are used independent of one another in the formation of subsets of electrodes for said analysis. 5
103. An integrated system of claim 95 wherein the sample preparation includes further reaction steps after said heater induced lysis.
104. An integrated system of claim 103 wherein the further reaction includes enzymatic reaction. 10
105. An integrated system of claim 103 wherein the further reaction includes chemical reaction.
106. An integrated system of claim 103 wherein the further reaction includes 15 protease reactions.
107. An integrated system of claim 106 wherein the protease reaction includes protease-K reaction. 20
108. An integrated system of claim 103 wherein the further reaction includes an amplification reaction.
109. An integrated system of claim 108 wherein the amplification includes SDA. 25
110. An integrated system of claim 108 wherein the amplification includes PCR.
111. An integrated system of claim 108 wherein the amplification includes linear amplification. 30
112. An integrated system of claim 108 wherein the amplification includes exponential amplification. WO 00/37163 PCTIUS99/31098 36
113. An integrated system of claim 95 wherein the power source provides a time varying signal to at least certain of the electrodes.
114. An integrated system of claim 113 wherein the time varying signal includes 5 an AC component.
115. An integrated system of claim 114 wherein the AC component is sinusoidal. 10
116. An integrated system of claim 113 wherein the time varying signal includes an offset signal.
117. An integrated system of claim 116 wherein the offset is a DC offset. 15
118. An integrated system of claim 95 further including a control system.
119. An integrated system of claim 118 wherein the control system is a computer. 20
120. An integrated system of claim 119 wherein the computer is a personal computer.
121. An integrated system of claim 120 wherein the personal computer is a notebook computer. 25
122. An integrated system of claim 95 wherein the first flow cell of the nonelectronic system includes at least one port in addition to the input and the output ports. 30
123. An integrated system of claim 122 wherein the first flow cell of the nonelectronic system includes at least two ports in addition to the input and the output ports. WO 00/37163 PCTIUS99/31098 37
124. An integrated system of claim 123 wherein the ports are at substantially 90 degrees to another port. 5
125. An integrated system of claim 122 wherein at -least two of the ports are in opposition to one another.
126. An integrated system of claim 95 further including at least two heater elements. 10
127. An integrated system of claim 126 wherein a heater is disposed on the electronic system.
128. An integrated system of claim 126 wherein a heater element is in thermal 15 contact with either of the nonelectronic or electronic systems.
129. An integrated system of claim 95 wherein the detector is a CCD detector.
130. An integrated system of claim 95 wherein the system is a closed system. 20
131. An integrated system of claim 95 wherein the system is a self contained system.
132. An integrated system of claim 95 wherein the system further includes a 25 fluidic system.
133. An integrated system of claim 132 wherein the fluidic system includes a pump. 30
134. An integrated system of claim 132 wherein the fluidic system includes a plurality of valves. WO 00/37163 PCT/US99/31098 38
135. An integrated system of claim 95 wherein the sample analysis includes binding of molecules to the array selected from the group consisting of hybridization and protein-ligand binding interactions. 5
136. An integrated system of claim 135 wherein the hybridization is DNA-DNA hybridization.
137. An integrated system of claim 135 wherein the hybridization is DNA/RNA hybridization. 10
138. An integrated system of claim 135 wherein the hybridization is pNA/nucleic acid hybridization.
139. An integrated of claim 135 wherein the protein-ligand binding is selected 15 from the group consisting of receptor-ligand, antigen-antibody, and enzyme-substrate binding.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11373098P | 1998-12-23 | 1998-12-23 | |
US60/113730 | 1998-12-23 | ||
PCT/US1999/031098 WO2000037163A1 (en) | 1998-12-23 | 1999-12-22 | Integrated portable biological detection system |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2595000A true AU2595000A (en) | 2000-07-12 |
AU763514B2 AU763514B2 (en) | 2003-07-24 |
Family
ID=22351155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU25950/00A Ceased AU763514B2 (en) | 1998-12-23 | 1999-12-22 | Integrated portable biological detection system |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1144092A4 (en) |
JP (1) | JP2002536962A (en) |
KR (1) | KR20010102961A (en) |
AU (1) | AU763514B2 (en) |
BR (1) | BR9916840A (en) |
CA (1) | CA2353461A1 (en) |
NZ (1) | NZ512087A (en) |
WO (1) | WO2000037163A1 (en) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6379897B1 (en) | 2000-11-09 | 2002-04-30 | Nanogen, Inc. | Methods for gene expression monitoring on electronic microarrays |
CN1181337C (en) | 2000-08-08 | 2004-12-22 | 清华大学 | Solid molecule operating method in microfluid system |
US6884395B2 (en) | 2000-05-12 | 2005-04-26 | Gyros Ab | Integrated microfluidic disc |
US6261785B1 (en) * | 2000-07-27 | 2001-07-17 | Becton, Dickinson And Company | Amplification and detection of Bordetella pertussis |
US6277582B1 (en) * | 2000-07-27 | 2001-08-21 | Becton, Dickinson And Company | Amplification and detection of mycoplasma pneumoniae targeting the P1 gene |
US6251609B1 (en) * | 2000-07-27 | 2001-06-26 | Becton, Dickinson And Company | Amplification and detection of Legionella pneumophila targeting the mip gene |
CN100495030C (en) | 2000-09-30 | 2009-06-03 | 清华大学 | Multi-force operator and use thereof |
JP4505776B2 (en) * | 2001-01-19 | 2010-07-21 | 凸版印刷株式会社 | Gene detection system, gene detection apparatus equipped with the same, detection method, and gene detection chip |
KR100393131B1 (en) * | 2001-03-15 | 2003-07-31 | 케이맥(주) | Method for crystalizing proteins in nano scale, and chamber for crystalizing proteins and chip comprising the same |
US6890409B2 (en) | 2001-08-24 | 2005-05-10 | Applera Corporation | Bubble-free and pressure-generating electrodes for electrophoretic and electroosmotic devices |
GB0205455D0 (en) | 2002-03-07 | 2002-04-24 | Molecular Sensing Plc | Nucleic acid probes, their synthesis and use |
KR100830926B1 (en) * | 2002-03-27 | 2008-05-22 | 일렉트론 바이오 (주) | Bio-Disc, Bio-Driver apparatus, and Assay method using the same |
US20040058423A1 (en) * | 2002-05-03 | 2004-03-25 | Nancy Albritton | Fast electrical lysis of cells and rapid collection of the contents thereof using capillary electrophoresis |
KR100441893B1 (en) * | 2002-08-03 | 2004-07-27 | 학교법인 포항공과대학교 | Nucleic acid separation device using MEMS component |
JP4216018B2 (en) * | 2002-08-26 | 2009-01-28 | 賢二 安田 | Nucleic acid recovery chip and nucleic acid recovery device |
ATE531257T1 (en) | 2002-09-27 | 2011-11-15 | Gen Hospital Corp | MICROFLUIDIC DEVICE FOR CELL SEPARATION AND USES THEREOF |
US7217542B2 (en) * | 2002-10-31 | 2007-05-15 | Hewlett-Packard Development Company, L.P. | Microfluidic system for analyzing nucleic acids |
AU2004212464A1 (en) * | 2003-02-05 | 2004-08-26 | Board Of Regents, The University Of Texas System | A microchip-based system for HIV diagnostics |
EP1746158A4 (en) * | 2004-05-07 | 2009-11-25 | Konica Minolta Med & Graphic | Micro-reactor for testing, genetic testing apparatus, and genetic testing method |
US20070196820A1 (en) | 2005-04-05 | 2007-08-23 | Ravi Kapur | Devices and methods for enrichment and alteration of cells and other particles |
US8921102B2 (en) | 2005-07-29 | 2014-12-30 | Gpb Scientific, Llc | Devices and methods for enrichment and alteration of circulating tumor cells and other particles |
DE102005059536B4 (en) | 2005-12-13 | 2008-08-28 | Siemens Ag | Method and biochip for studying a biological sample |
EP2589668A1 (en) | 2006-06-14 | 2013-05-08 | Verinata Health, Inc | Rare cell analysis using sample splitting and DNA tags |
US20080050739A1 (en) | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
CN101544351B (en) * | 2009-05-08 | 2011-12-14 | 东南大学 | Low-dimensional nanophase material high-flexibility assembling chip and application method |
WO2015044191A1 (en) | 2013-09-24 | 2015-04-02 | Ait Austrian Institute Of Technology Gmbh | Method for pathogen isolation |
US10537889B2 (en) | 2013-12-31 | 2020-01-21 | Illumina, Inc. | Addressable flow cell using patterned electrodes |
EP3112869A1 (en) * | 2015-06-30 | 2017-01-04 | IMEC vzw | Sensor device |
GB201704761D0 (en) * | 2017-01-05 | 2017-05-10 | Illumina Inc | Common line selector valve for a system |
KR102562371B1 (en) * | 2021-08-19 | 2023-08-02 | (주)엠큐빅 | Microalgae analysis device using artificial intelligence |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4661451A (en) * | 1984-02-06 | 1987-04-28 | Ortho Diagnostic Systems, Inc. | Methods for immobilizing and translocating biological cells |
US5795457A (en) * | 1990-01-30 | 1998-08-18 | British Technology Group Ltd. | Manipulation of solid, semi-solid or liquid materials |
US5605662A (en) * | 1993-11-01 | 1997-02-25 | Nanogen, Inc. | Active programmable electronic devices for molecular biological analysis and diagnostics |
US6071394A (en) * | 1996-09-06 | 2000-06-06 | Nanogen, Inc. | Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis |
US5856174A (en) * | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
GB9615775D0 (en) * | 1996-07-26 | 1996-09-04 | British Tech Group | Apparatus and method for characterising particles using dielectrophoresis |
-
1999
- 1999-12-22 JP JP2000589268A patent/JP2002536962A/en active Pending
- 1999-12-22 EP EP19990968558 patent/EP1144092A4/en not_active Withdrawn
- 1999-12-22 AU AU25950/00A patent/AU763514B2/en not_active Ceased
- 1999-12-22 CA CA002353461A patent/CA2353461A1/en not_active Abandoned
- 1999-12-22 NZ NZ512087A patent/NZ512087A/en unknown
- 1999-12-22 KR KR1020017007947A patent/KR20010102961A/en not_active Application Discontinuation
- 1999-12-22 BR BR9916840-5A patent/BR9916840A/en not_active IP Right Cessation
- 1999-12-22 WO PCT/US1999/031098 patent/WO2000037163A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2000037163A1 (en) | 2000-06-29 |
EP1144092A4 (en) | 2002-10-29 |
EP1144092A1 (en) | 2001-10-17 |
CA2353461A1 (en) | 2000-06-29 |
BR9916840A (en) | 2001-10-09 |
NZ512087A (en) | 2003-05-30 |
AU763514B2 (en) | 2003-07-24 |
KR20010102961A (en) | 2001-11-17 |
JP2002536962A (en) | 2002-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6403367B1 (en) | Integrated portable biological detection system | |
AU763514B2 (en) | Integrated portable biological detection system | |
US6638482B1 (en) | Reconfigurable detection and analysis apparatus and method | |
US6309602B1 (en) | Stacked, reconfigurable system for electrophoretic transport of charged materials | |
US6319472B1 (en) | System including functionally separated regions in electrophoretic system | |
JP7318975B2 (en) | Nucleic acid sample preparation | |
US7857957B2 (en) | Integrated portable biological detection system | |
US6375899B1 (en) | Electrophoretic buss for transport of charged materials in a multi-chamber system | |
US20040077074A1 (en) | Multi-chambered analysis device | |
AU743074B2 (en) | Channel-less separation of bioparticles on a bioelectronic chip by dielectrophoresis | |
US6129828A (en) | Apparatus and methods for active biological sample preparation | |
JP3558294B2 (en) | Polynucleotide amplification analysis using microfabrication equipment | |
US20010006785A1 (en) | Method and apparatus for analyzing nucleic acids | |
MXPA02001437A (en) | Microfluidic devices for the controlled manipulation of small volumes. | |
US20120071365A1 (en) | Detection Device Having Increased Detection Rate, and Method for Quick Detection of Biological Molecules | |
WO2000032744A9 (en) | Apparatus and methods for transport of charged biological materials | |
Cheng et al. | Fluorescent imaging of cells and nucleic acids in bioelectronic chips | |
AU5197000A (en) | Method for selective isolation of desired charged biological materials from undesired charged materials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGA | Letters patent sealed or granted (standard patent) |